STERIS
STESTERIS plc is a leading global provider of infection prevention and procedural products and services focused on healthcare, medical device, and pharmaceutical markets.
Earnings
Next report
Nov 4, 2026 (in 2 months)Segments
Competitors
By market cap
By revenue growth
Profile
STERIS plc is a leading global provider of infection prevention and procedural products and services focused on healthcare, medical device, and pharmaceutical markets. The company helps customers create a healthier and safer world through a unique mix of consumables, capital equipment, and outsourced services. Its core value proposition centers on supporting patient care through comprehensive sterilization, disinfection, and surgical solutions.
A leading global provider with a significant installed base of capital equipment and a comprehensive network of contract sterilization facilities.
FAQ
- What is STERIS's market cap?
- STERIS (STE) has a market capitalization of $20.5B and trades on NYSE.
- What is STERIS's revenue and profitability?
- STERIS generated $6.0B in trailing twelve-month revenue with net income of $805.1M, representing a net margin of 13.3%. Gross margin stands at 44.4%, with free cash flow of $925.6M. The latest reported period is Q1 2027.
- Who are STERIS's competitors?
- STERIS's key competitors include Sterigenics International, Inc., Fortive, Ecolab, and others. These companies compete in similar markets and product categories.
- Where is STERIS headquartered?
- STERIS is headquartered in Ireland and employs approximately 18,179 people. It has been publicly traded since 1992.
